Navigation Links
Kayentis, the Leading Provider of the Unique "Paper-Based e-Trial" Solution, has been Retained for Six New Clinical Studies in the US Market
Date:9/23/2009

Kayentis, the global leader of digital pen and paper technology and the unique provider of "paper-based e-trial" solution, today announced that it has been retained for six new clinical studies conducted in the US, therefore continuing and strengthening its expansion in North America.

Philadelphia, PA / Gif sur Yvette, France (PRWEB) September 22, 2009 -- Kayentis offers Clin'Form, the optimal paper-based e-data capture solution for clinical trials. Clin'Form combines the best that the physical and the digital worlds have to offer. It is the easiest and most reliable data collection method for both patients and physicians (pen & paper), resulting in the highest quality of data captured. These benefits are combined with all the advantages of electronic data management (real-time access, data sharing, audit trail functionalities, alerts, etc.); while providing accurate timestamps and significantly streamlining clinical trial costs.

Six US pharmaceutical companies have retained Clin'Form to run their clinical studies, involving investigators and patients (CRF and PRO). "We are much honored to have been retained by our new sponsors. Clin'Form, our Digital Pen and Paper based data capture solution, helps them improve the quality of the data captured and significantly reduces the steps required for the deployment of a study - and in doing so simultaneously saves time and costs dramatically" comments Guy Maestre, Kayentis Vice President, North American Operations. "It provides a decisive advantage for life sciences companies in the implementation of their clinical trials while end-users (investigators, CRAs, patients) benefit from a very natural way to capture clinical data."

Clin'Form has been successfully deployed in studies conducted in more than 40 countries, in over forty different languages, and involving over 50 000 patients across all continents.

ABOUT KAYENTIS
Kayentis provides software solutions dedicated to each stage of a drug's life cycle development. It offers key solutions to collect, display, share and archive information and clinical data. Kayentis Clin'Form solution, enabling Anoto functionality, is the optimal paper-based e-data capture solution for clinical trials.
Kayentis is a member of Pennsylvania BIO and BIO New Jersey. Kayentis is an Anoto Platinum Partner, an Oracle Partner and an HP Solution Business Partner.

To discover more about this unique solution please visit www.kayentis.com.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2924304.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... for the electronic prescribing of controlled and non-controlled substances plus the ability to ... pharmacies in the United States now accept electronic prescriptions, according to the Office ...
(Date:2/17/2017)... Church, VA (PRWEB) , ... February 17, 2017 ... ... Implementing the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, ... , Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? ...
(Date:2/17/2017)... Austin, Tx (PRWEB) , ... February 17, 2017 ... ... of revenue cycle management services, announced today that Karen Pilley has been promoted ... expenses is critical in today’s shifting healthcare paradigm – a shift that demands ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow ... part by the Hospital Readmission Reduction Program (HRRP), the return of a patient to ... hospitals across the nation. While many providers are struggling to leverage limited resources and ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... (NYSE: DVA ) today announced results for the ... Net income attributable to DaVita Inc. for the quarter and ... per share and $880 million, or $4.29 per share, respectively. ... for the quarter and year ended December 31, 2016, excluding ... per share, and $789 million, or $3.85 per share, respectively. ...
(Date:2/16/2017)... ST. LOUIS , Feb. 16, 2017  Express Scripts (NASDAQ: ... one of the World,s Most Admired Companies within the Health Care: ... to be named one of the World,s Most Admired Companies," said ... is driven by the commitment and passion of our 26,000 employees ... people we serve." ...
(Date:2/16/2017)... Research and Markets has announced the addition of the "Global ... Cancer Type, Technology - Forecast to 2025" report to their ... The ... a CAGR of around 28.6% over the next decade to reach ... the prominent trends that the market is witnessing include increasing demand ...
Breaking Medicine Technology: